Follow the Hikal Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Hikal Limited has logged 10 public disclosures. Market capitalisation: €26.9bn. The latest transaction was reported on 18 February 2026 (Purchase). Among the most active insiders: Ashok Vishwanath Hiremath. The full history is free.
10
Insider Decl.
n/a
Thresholds
€2m
8 ops.
Buy Volume
€577,913
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Hikal Limited Strong Buy (bullish), based on 1 analysts. Average price target: ₹300.00.
19Σ signal
Buys €2m€577,913 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,395 of 29,064 companies
38.2
score / 100
Value
38
Quality
38
FCF yld5.7%
Earn yld-1.8%
EV/EBITDA22.8x
ROE·
Gross mgn55%
Net mgn-2.9%
Debt/EBITDA4.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
15,000 shares@ ₹354.876215.0% of flowEquity SharesSEBI:9748e4072446120a0e51f9cec181435eba617482
10 of 10 declarations
Acerca de Hikal Limited
Hikal Limited es una empresa que opera en el sector de la salud y farmacéutico, especializada en la fabricación de productos químicos y farmacéuticos. Cotiza en el mercado XBOM.